Compass Therapeutics Stock

compasstherapeutics.comHealthcareFounded: 2018

Compass Therapeutics developing proprietary antibody therapeutics to treat both solid tumors and hematologic malignancies.

Register for Details

For more details on financing and valuation for Compass Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Compass Therapeutics.

Register Today

Other companies like Compass Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector